Mainly, this happened because investors looked to whether Democrats or Republicans would control Congress as an indicator of how likely it would be for new health initiatives to become law.
It appears Democrats will retain control of the House of Representatives, but both parties had tied for 48 seats in the Senate as of Nov. 9. Four races still hadn’t been called, though Republican candidates currently lead in Alaska and North Carolina’s Senate races, according to the APM Research Lab.
John Barnidge, an analyst for investment banking company Piper Sandler, told S&P Global Market Intelligence that control of Congress will be the most important outcome for health insurers. It will likely be challenging for progressive healthcare legislation to pass both chambers, meaning insurers can expect relatively small changes to their business under the new president-elect.
More articles on payers:
500+ BCBS of Michigan employees take buyouts
UnitedHealth ordered to reprocess 67,000 mental health claims
CMS releases second part of Medicare Advantage, Part D rule: 3 things to know
